sobral
27-09-12, 00:13
http://i971.photobucket.com/albums/ae197/ScottyDoc/IGNITE-2flyer-front.jpg
http://i971.photobucket.com/albums/ae197/ScottyDoc/IGNITE-2flyer-Back.jpg
http://www.nutritionjungle.com/images/products/rd-labs/elements/NO-IGNITE-FACTS.png
.
Fact... The majority of all concentrated pre-workouts contain more than 50% ingredients that cause thermogenesis, which translates into weight loss, which can have a negative impact on the growth of lean muscle!
IGNITE 2 contains ingredients that will actually promote muscle growth....
Aminosterone - patent pending d-aspartic acid that is 400 times more soluble than regular DAA
Instantized BCAA - prevent muscle break down
Crea-trona - patented in Europe and patent pending in the USA. We are the first company in the USA to use this ingredient. Most bioavailable creatine on the market
Full dosage of Carnosyn (beta alanine)
οκ τα προηγούμενα που ανέβασα αλλά την βόμβα την άφησα για το τέλος.:turtle::turtle: ΤΟΥΜΠΑΝΟ!
DAA diethyl ester HCL patent pending γράφουν. what is this? θα πέσει διάβασμα τώρα, να δούμε...
http://i971.photobucket.com/albums/ae197/ScottyDoc/IGNITE-2flyer-Back.jpg
http://www.nutritionjungle.com/images/products/rd-labs/elements/NO-IGNITE-FACTS.png
.
Fact... The majority of all concentrated pre-workouts contain more than 50% ingredients that cause thermogenesis, which translates into weight loss, which can have a negative impact on the growth of lean muscle!
IGNITE 2 contains ingredients that will actually promote muscle growth....
Aminosterone - patent pending d-aspartic acid that is 400 times more soluble than regular DAA
Instantized BCAA - prevent muscle break down
Crea-trona - patented in Europe and patent pending in the USA. We are the first company in the USA to use this ingredient. Most bioavailable creatine on the market
Full dosage of Carnosyn (beta alanine)
οκ τα προηγούμενα που ανέβασα αλλά την βόμβα την άφησα για το τέλος.:turtle::turtle: ΤΟΥΜΠΑΝΟ!
DAA diethyl ester HCL patent pending γράφουν. what is this? θα πέσει διάβασμα τώρα, να δούμε...